LY2835219 mesylate/ LIDE PHARMA- Factory supply / Best price
Min.Order / FOB Price:Get Latest Price
| 1 Gram |
Negotiable |
- Min.Order :1 Gram
- Purity: 99%min.
- Payment Terms : T/T,,MoneyGram
Keywords
LY2835219 mesylate Bemaciclib mesylate Abemaciclib mesylate
Quick Details
- Appearance:White powder
- Application:LY2835219 is an orally-bioavailable dual inhibitor of cyclin-dependent kinase 4 (CDK4) and CDK6 (IC50s = 2 and 10 nM, respectively). Through this mechanism, it blocks phosphorylation of retinoblastoma
- PackAge:1g/Al-foiled bag; 10g/Al-foiled bag; 100g/Al-foiled bag; 1kg/Al-foiled bag or Al-tin
- ProductionCapacity:10|Kilogram|Month
- Storage:Storage: In well-closed container, protected from light and in cool & dry place.
- Transportation:By air, by courier(FedEx/DHL/EMS),by sea
Superiority:
Advantage :
LIDE PHARMACEUTICALS LIMITED is a professional chemicals and APIs leading manufacturer in China. Our core business line covers APIs, Intermediates, etc.
We are specialized in chemical synthesis, process development of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and rare chemicals.
We also accept custom synthesis project and contract research services like CRO, CMO and CDMO.
R&D strength:
We have well equipped chemicals and instrumental laboratories with modern instruments such as HPLC,GC,IR,UV,NMR,LC-MS etc.
At present, we are selling it with good discount for immediate delivery ! BOOKING TO HASTEN !
Details:
(1) Company profile:
Company profile: Lide Pharmaceuticals Limited
Main products: APIs; Intermediate and other fine chemical products; Piperazine series; Custom Synthesis; CRO; CMO; CDMO.
Main Markets: North America; South America; Eastern Europe; Southeast Asia; Africa Oceania; Mid East; Eastern Asia; Western Europe, etc.
(2) Product:
Product Name: LY2835219 mesylate; Bemaciclib mesylate; Abemaciclib mesylate
CAS No.: 1231930-82-7
Molecular Formula: C28H36F2N8O3S
Molecular Weight: 602.69
Appearance: White crystalline powder
Specification: 99%min.
(3) Application:
LY2835219 is an orally-bioavailable dual inhibitor of cyclin-dependent kinase 4 (CDK4) and CDK6 (IC50s = 2 and 10 nM, respectively). Through this mechanism, it blocks phosphorylation of retinoblastoma protein, resulting in arrest of cell cycling in the G1 phase. LY2835219 has antitumor action against xenografts when used alone or in combination with other chemotherapeutic compounds.[Cayman Chemical]
You Might Also Like
-
Vanillyl butyl ether / LIDE PHARMA- Factory supply / Best price
CAS NO:82654-98-6
-
Vandetanib/ LIDE PHARMA- Factory supply / Best price
CAS NO:443913-73-3
-
Drostanolone Enanthate/ LIDE PHARMA- Factory supply / Best price
CAS NO:58-19-5
-
Posaconazole
CAS NO:171228-49-2
-
LGD-4033;LGD 4033 factory/Lide Pharma
CAS NO:1165910-22-4
-
RAD140
CAS NO:1182367-47-0
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View